Adjunctive corticosteroid therapy for inpatients with Mycoplasma pneumoniae pneumonia

There is conflicting evidence regarding the benefit of adjunctive corticosteroid therapy in patients with Mycoplasma pneumoniae pneumonia. We hypothesised that corticosteroid therapy could reduce mortality and length of stay (LOS) in such patients.